The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States.
Lesley H Curtis; Jennifer Stoddard; Jasmina I Radeva; Steve Hutchison; Peter E Dans; Alan Wright; Raymond L Woosley; Kevin A Schulman (Profiled Author: Peter Dans)
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, P.O. Box 17969, Durham, NC 27715, USA.
Health services research 2006;41(3 Pt 1):837-55.
OBJECTIVE: To measure geographic variation in opioid use in a large, commercially insured, outpatient population in the United States. DATA SOURCES: Outpatient prescription drug claims database of a national pharmaceutical benefit manager for 7,873,337 subjects with at least one prescription drug claim in 2000. STUDY DESIGN: We measured the period prevalence of claims for opioid analgesics and controlled-release oxycodone at the state level. We measured geographic variation using the weighted coefficient of variation and systematic component of variation. In county-level multivariable regression, we explored associations between potential explanatory variables and claims for opioid analgesics and controlled-release oxycodone. PRINCIPAL FINDINGS: A total of 567,778 (64.2 per 1,000 total claims) were for oral opioid analgesics. Claim rates by state ranged from <20 to >100 claims per 1,000 total claims. States with long-standing prescription monitoring programs had among the lowest rates. In the county-level data, presence of a statewide prescription monitoring program and proportions of the population aged 15-24 and 65 years and older were independently and negatively associated with claim rates for all opioid analgesics. Surgeons per 1,000, proportion of the population reporting illicit drug use, and proportion who were female were independently and positively associated with claim rates for all opioid analgesics. Only the proportion of the population aged 25-34 and number of surgeons per 1,000 were independently and positively associated with claim rates for oxycodone. CONCLUSIONS: Claim rates for opioid analgesics vary significantly by state. Presence of a statewide prescription monitoring program is associated with lower claim rates at the county level. Future research should use individual-level data to assess whether these findings reflect a reduction in abuse and diversion or suboptimal treatment of pain.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Theodore J Cicero; Richard C Dart; James A Inciardi; George E Woody; Sidney Schnoll; Alvaro MuñozPain medicine (Malden, Mass.) 2007;8(2):157-70.
N P Katz; D C Buse; S H Budman; S Wing Venuti; K C Fernandez; C Benoit; R Bianchi; D Cooper; D R Jasinski; D E Smith; et al.Drug development and industrial pharmacy 2006;32(6):727-46.
Rebecca Heltsley; Anne Zichterman; David L Black; Beverly Cawthon; Tim Robert; Frank Moser; Yale H Caplan; Edward J ConeJournal of analytical toxicology 2010;34(1):32-8.
Appears in this Publication
Author of this Publication